| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.0M | +81.7% |
| Cost of Revenue | $10.3M | -5.1% |
| Gross Profit | $4.7M | +285.5% |
| R&D Expense | $1.7M | +556.3% |
| SG&A Expense | $8.6M | +50.1% |
| Operating Income | -$6.9M | +7.9% |
| Interest Expense | $9K | -54.7% |
| Net Income | -$6.9M | -14.2% |
| EPS (Basic) | -$1.11 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.4M | +96.6% |
| Inventory | $1.4M | +378.8% |
| Current Assets | $6.8M | +107.8% |
| Total Assets | $13.1M | +38.0% |
| Current Liabilities | $4.5M | +14.1% |
| Total Liabilities | $9.0M | +3.9% |
| Stockholders' Equity | $4.1M | +418.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.9M | -19.7% |
| Capital Expenditures | $345K | -36.8% |
| Investing Cash Flow | -$645K | -16.6% |
| Financing Cash Flow | $8.7M | +115.6% |
| Free Cash Flow | -$8.2M | -15.3% |
| +31.9% |
| EPS (Diluted) | -$1.11 | +31.9% |